StemCells, Inc. to Present at 2013 BIO CEO & Investor Conference
06 févr. 2013 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., Feb. 6, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that President and CEO Martin McGlynn will present an update on the Company's programs and operations at...
StemCells, Inc. to Present at Phacilitate Cell & Gene Therapy Forum
23 janv. 2013 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., Jan. 23, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Ann Tsukamoto, Ph.D., Executive Vice President, Research and Development, will make a presentation...
StemCells, Inc. to Present at 2012 World Stem Cell Summit
29 nov. 2012 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., Nov. 29, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Ann Tsukamoto, Ph.D., Executive Vice President, Research and Development, will make a presentation...
StemCells, Inc. Reports Third Quarter 2012 Financial Results and Provides Business Update
08 nov. 2012 16h05 HE
|
StemCells, Inc.
NEWARK, Calif., Nov. 8, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. Announces Webcast to Discuss Third Quarter 2012 Financial Results and Business Update
05 nov. 2012 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., Nov. 5, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. Partners With R Biomedical to Develop and Commercialize Reagents for Human iPS Cell Research
30 oct. 2012 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., Oct. 30, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that it has partnered with R Biomedical, an Edinburgh, UK-based biomedical company, to develop and...
StemCells, Inc. to Present at 2012 Stem Cell Meeting on the Mesa's Investor and Partnering Forum
26 oct. 2012 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., Oct. 26, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that President and CEO Martin McGlynn will make a presentation on the Company's programs and operations...
StemCells, Inc. Adds Eliseo Salinas to Advise on Product Development Strategy for Its Proprietary Human Neural Stem Cells
18 oct. 2012 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., Oct. 18, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced it has retained Eliseo Oreste Salinas, MD, MSc, on an exclusive basis, to help formulate and execute the...
Ascendiant Capital Markets Initiates Research Coverage of StemCells, Inc. With Buy Recommendation
17 oct. 2012 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., Oct. 17, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Ascendiant Capital Markets, LLC initiated independent research coverage on the Company with a "Buy"...
StemCells, Inc. Launches Four New Human Neural Stem Cell Kits Under SC Proven(R) Brand
16 oct. 2012 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., Oct. 16, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today the launch of four new SC Proven human neural stem cell (NSC) kits for use in neuroscience research....